Explore obesity case studies profiling semaglutide, tirzepatide, and retatrutide using Eurofins Discovery’s weight-loss solutions.
Advance your obesity program with on/off-target panels, translational assays, in vivo models, and MOA-reflective tools.
Partner with expert scientists and program managers for strategic guidance and scientific leadership on your integrated drug discovery programs targeting weight-loss therapeutics.
